Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia

Official title: Enhancing Cardiometabolic Health in Postnatal Women at High-Risk for Preeclampsia Through Exercise Intervention

Run by Chinese University of Hong Kong · NCT07921173 · Data updated 2026-11-12

This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment40 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedSeptember 3, 2026
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07921173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–45 who had a pregnancy complicated by hypertension and developed a hypertensive disorder, currently 6–8 weeks postpartum, and able to participate in an exercise program.

Probably not a fit

Individuals with conditions that contraindicate exercise or who do not respond to physical activity may see no notable cardiometabolic benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study enrolls 40 women 6 to 8 weeks after delivery who had a hypertensive disorder of pregnancy and are at high risk for preeclampsia. Participants are randomized to a 12‑week program of aerobic, resistance, and pelvic floor exercises three times per week or standard postnatal care. Outcomes include cardiovascular function, blood pressure, metabolic blood markers, fitness, body composition, mood, sleep, and health-related quality of life, measured before and after the program. The trial aims to determine if structured postpartum exercise can benefit cardiometabolic health in this high‑risk population.

Why it matters

Potential benefit: If successful, participants could experience improvements in cardiovascular health and metabolic risk factors after delivery.

How similar studies have gone: Prior studies in postpartum populations suggest exercise can improve cardiometabolic health, but evidence in women with prior hypertensive disorders of pregnancy is limited and this trial addresses a specific high‑risk group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 to 45 years.
* Identified as being at high risk for preeclampsia during the most recent pregnancy and developed a hypertensive disorder of pregnancy (HDP).
* Had a singleton pregnancy.
* 6 to 8 weeks postpartum at enrollment.
* Physically able to participate in the exercise training program.
* Willing to participate in the study and provide informed consent.

Exclusion Criteria:

* Had a multiple pregnancy.
* Severe medical complications after delivery or other health conditions that contraindicate physical exercise (e.g., severe cardiovascular disease or musculoskeletal disorders).
* Chronic hypertension or diabetes before pregnancy.
* Current use of medication that could potentially affect cardiac function (e.g., medication for heart failure).
* Received antibiotic treatment within the past month.
* Severe mental health disorders that affect the ability to exercise.
* Unable or unwilling to adhere to and attend the 12-week exercise program.

Where it's running

  • Department of Obstetrics & Gynaecology, Prince of Wales Hospital
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.